Clearance Summary
EU-TTG IGA AND EU-TTG IGG received FDA 510(k) clearance under submission number K102964, sponsored by Grifols USA, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2011-03-07.
- Submission: K102964
- Applicant / Sponsor: Grifols USA, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5660
- Decision date: 2011-03-07
Classification & Regulation
This clearance is catalogued under FDA product code MVM and 21 CFR 866.5660, within the Immunology review panel as a Class II device.